JP Morgan Chase’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.8K | Sell |
383
-2,155
| -85% | -$13.6K | ﹤0.01% | 7034 |
|
|
2025
Q4 | $22.5K | Sell |
2,538
-10
| -0.4% | -$126 | ﹤0.01% | 6476 |
|
|
2025
Q3 | $33.1K | Buy |
2,548
+2,365
| +1,292% | +$29.2K | ﹤0.01% | 6360 |
|
|
2025
Q2 | $2.27K | Sell |
183
-7,746
| -98% | -$92.6K | ﹤0.01% | 6520 |
|
|
2025
Q1 | $80K | Sell |
7,929
-16,157
| -67% | -$196K | ﹤0.01% | 5672 |
|
|
2024
Q4 | $341K | Buy |
24,086
+14,110
| +141% | +$275K | ﹤0.01% | 5237 |
|
|
2024
Q3 | $227K | Buy |
9,976
+6,376
| +177% | +$129K | ﹤0.01% | 5347 |
|
|
2024
Q2 | $64.3K | Buy |
3,600
+3,594
| +59,900% | +$79.5K | ﹤0.01% | 5747 |
|
|
2024
Q1 | $169 | Hold |
6
| – | – | ﹤0.01% | 6828 |
|
|
2023
Q4 | $83 | Hold |
6
| – | – | ﹤0.01% | 7142 |
|
|
2023
Q3 | $69 | Hold |
6
| – | – | ﹤0.01% | 6954 |
|
|
2023
Q2 | $118 | Hold |
6
| – | – | ﹤0.01% | 6679 |
|
|
2023
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 6678 |
|
|
2022
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 6531 |
|
|
2022
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 6447 |
|
|
2022
Q2 | $0 | Sell |
6
-3,658
| -100% | -$57.6K | ﹤0.01% | 6451 |
|
|
2022
Q1 | $69K | Buy |
3,664
+779
| +27% | +$15.8K | ﹤0.01% | 5660 |
|
|
2021
Q4 | $69K | Sell |
2,885
-2,320
| -45% | -$84.9K | ﹤0.01% | 5820 |
|
|
2021
Q3 | $254K | Sell |
5,205
-5,217
| -50% | -$303K | ﹤0.01% | 5107 |
|
|
2021
Q2 | $988K | Buy |
+10,422
| New | +$552K | ﹤0.01% | 4305 |
|
|
2019
Q4 | – | Sell |
-757
| Closed | -$22K | – | 5599 |
|
|
2019
Q3 | $22K | Buy |
+757
| New | +$24K | ﹤0.01% | 5389 |
|
Other funds holding ATOS
VCM
VFT
